- Open Access
Correction to: Cerebral nocardiosis in a patient treated with pembrolizumab: a first case report
BMC Infectious Diseases volume 22, Article number: 371 (2022)
Correction to: BMC Infectious Diseases (2022) 22:306 https://doi.org/10.1186/s12879-022-07288-4
Following publication of the original article , the authors identified that the given names and family names were erroneously transposed.
The incorrect authors’ names list is:
Petitgas Paul1,2*, Lesouhaitier Mathieu1, Boukthir Sarrah3, Cattoir Vincent3, Tattevin Pierre1 and Bénézit François1.
The correct authors’ names list is:
Paul Petitgas1,2,*, Mathieu Lesouhaitier1, Sarrah Boukthir3, Vincent Cattoir3, Pierre Tattevin1 and François Bénézit1.
The author group has been updated above and the original article  has been corrected.
Petitgas P, Lesouhaitier M, Boukthir S, Cattoir V, Tattevin P, Bénézit F. BMC Infect Dis. 2022;22:306. https://doi.org/10.1186/s12879-022-07288-4.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Petitgas, P., Lesouhaitier, M., Boukthir, S. et al. Correction to: Cerebral nocardiosis in a patient treated with pembrolizumab: a first case report. BMC Infect Dis 22, 371 (2022). https://doi.org/10.1186/s12879-022-07343-0